Novartis' CEO on gene therapy, innovation, and the company pivot - STAT

Novartis' CEO on gene therapy, innovation, and the company pivot - STAT

STAT Plus: Novartis CEO Vas Narasimhan on gene therapy, innovation, and the company pivot

By KAREN WEINTRAUB

ALISSA AMBROSE/STAT

STAT spoke with Novartis CEO Vas Narasimhan about his acquisitions, his hopes for gene therapy, and the direction he plans to take the company.

READ MORE